BRAIDWELL LP 13D and 13G filings for Deciphera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:06 pm Sale | 2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | BRAIDWELL LP | 2,385,623 2.920% | -2,213,861 (-48.13%) | Filing |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | BRAIDWELL LP | 4,599,484 6.680% | 4,599,484 (New Position) | Filing |